TY - JOUR
T1 - Toxic
T2 - The Challenge of Involuntary Contraception in Incompetent Psychiatric Patients Treated with Teratogenic Medication
AU - Schwartzberg, Jordan L.
AU - King, Bridget
AU - Appel, Jacob M.
N1 - Publisher Copyright:
Copyright 2022 The Journal of Clinical Ethics. All rights reserved.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Limitations on reproductive decision making, including forced sterilization and involuntary birth control, raise significant ethical challenges. In the United States, these issues are further complicated by a disturbing history of the abuse and victimization of vulnerable populations. One particularly fraught challenge is the risk of teratogenicity posed by mood-stabilizing psychiatric medications in patients who are incapable of appreciating such dangers. Long-acting reversible contraception (LARC) offers an intervention to prevent pregnancy among individuals who receive such treatments, but at a cost to their reproductive autonomy. This article examines the ethical issues involved in the use of involuntary LARC for patients on teratogenic psychiatric medications (TPMs) and argues that such an approach can only be justified as a last resort after a careful consideration of the alternatives and an assessment of potential risks and benefits.
AB - Limitations on reproductive decision making, including forced sterilization and involuntary birth control, raise significant ethical challenges. In the United States, these issues are further complicated by a disturbing history of the abuse and victimization of vulnerable populations. One particularly fraught challenge is the risk of teratogenicity posed by mood-stabilizing psychiatric medications in patients who are incapable of appreciating such dangers. Long-acting reversible contraception (LARC) offers an intervention to prevent pregnancy among individuals who receive such treatments, but at a cost to their reproductive autonomy. This article examines the ethical issues involved in the use of involuntary LARC for patients on teratogenic psychiatric medications (TPMs) and argues that such an approach can only be justified as a last resort after a careful consideration of the alternatives and an assessment of potential risks and benefits.
UR - http://www.scopus.com/inward/record.url?scp=85126704456&partnerID=8YFLogxK
M3 - Article
C2 - 35302516
AN - SCOPUS:85126704456
VL - 33
SP - 29
EP - 35
JO - Journal of Clinical Ethics
JF - Journal of Clinical Ethics
SN - 1046-7890
IS - 1
ER -